Submitted by Anonymous (not verified) on 17 December 2025 - 14:17
Opinion/decision on a Paediatric investigation plan (PIP): Inaqovi, cedazuridine,decitabine, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Blood and lymphatic system disorders, PIP number: EMA/PE/0000182217
Source: